<DOC>
	<DOCNO>NCT02215798</DOCNO>
	<brief_summary>Primary objective : To estimate frequency adverse event , serious non-serious Filipino patient diabetic peripheral neuropathic pain treat duloxetine 60mg daily within study duration approximately 6-8 week naturalistic clinical setting . Secondary objective : To evaluate change baseline endpoint Brief Pain Inventory ( BPI ) Neuropathic Pain Questionnaire ( NPQ ) assess investigator duloxetine use treatment diabetic peripheral neuropathic pain among Filipino patient within study duration approximately 6-8 week naturalistic clinical setting .</brief_summary>
	<brief_title>Post-Marketing Surveillance Study Safety Efficacy Cymbalta ( Duloxetine ) Diabetic Peripheral Neuropathic Pain Among Filipino Patients</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Inclusion Criteria Are Filipino race Are male female outpatient least 18 year age Provide write consent release data inform study Are know diabetic clinically diagnose investigator Diabetic Peripheral Neuropathic Pain Are judge investigator reliable , agree keep appointment clinic visit , complete test procedure may require his/her attend physician course routine clinical care Treated duloxetine accord approve Product Information prescribe investigator routine care patient , without concomitant condition medication specify therein contraindicate Exclusion criterion Are investigator immediate family . Immediate family define investigator 's spouse , parent , naturally legally adopt child ( include stepchild living investigator 's household ) , grandparent , grandchild . Employees investigator also eligible Are simultaneously participate different study include treatment intervention and/or investigational drug Are hypersensitive duloxetine component Are pregnant and/or nurse mother Have concomitant condition contraindicate duloxetine treatment , describe Product Information ( e.g . liver disease result hepatic impairment , severe renal impairment ) Are concomitantly take contraindicated medication , describe Product Information ( e.g . fluvoxamine , ciprofloxacin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>